3,754
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cells

, , , , , , , , & ORCID Icon show all
Pages 47-53 | Received 10 Oct 2020, Accepted 10 Dec 2020, Published online: 05 Jan 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.